Pancreatic cancer: from molecular pathogenesis to targeted therapy (Q37144149)

18 August 2017

1 reference

title

Pancreatic cancer: from molecular pathogenesis to targeted therapy (English)

1 reference

18 August 2017

0 references

1 reference

Alexios Strimpakos

1

1 reference

18 August 2017

Muhammad W Saif

series ordinal

2

1 reference

18 August 2017

Kostas N Syrigos

series ordinal

3

1 reference

18 August 2017

1 September 2008

1 reference

Cancer and Metastasis Reviews

18 August 2017

1 reference

18 August 2017

27

1 reference

18 August 2017

3

1 reference

18 August 2017

495-522

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-008-9134-y

18 August 2017

0 references

cites work

Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Association of p53 gene mutations with short survival in pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Genetic alterations in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9134-Y

Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/IJC.21589

Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells.

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/1535-7163.MCT-05-0299

Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-05-4281

Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/CNCR.21904

Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-06-2333

Identifiers

DOI

10.1007/S10555-008-9134-Y

1 reference

release_hfssa3erjbfm7gdxrkny62i33e

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hfssa3erjbfm7gdxrkny62i33e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference